A general system has been devised for the in vivo construction of Candida albicans integrative vectors in Saccharomyces cerevisiae. The system is especially useful for the integration of genes in C. albicans that cannot be propagated in Escherichia coli, possibly because of their toxic effects. The ligation of S. cerevisiae 2 µ sequences to a C. albicans integrative vector permits in vivo maintenance and gap repair cloning within S. cerevisiae. After the vector assembly, it can be purified from S. cerevisiae or amplified by PCR and then used for transformation of C. albicans. The S. cerevisiae 2 µ sequence is completely removed by linearization prior to C. albicans transformation, such that no unwanted DNA is transferred in the final construct. The system was successfully used to clone and reintegrate the C. albicans JEN2 gene, which encodes a membrane protein that is apparently toxic to E. coli. Three popular C. albicans integrative vectors, CIp10, CIp20 and CIp30, are now available in versions that permit gap repair in S. cerevisiae. GenBank Accession Nos CIp10-2 µ (GU550119), CIp20-2 µ (GU550120) and CIp30-2 µ (GU550121).
Introduction
Candida albicans is a major fungal pathogen especially for patients with compromised immune systems (Odds, 1988) . Many of the molecular tools that have been developed for this organism are essentially based on those for the distantly related Saccharomyces cerevisiae. However, since C. albicans is an obligate diploid, gene disruptions must be carried out twice to inactivate both alleles for each gene (Berman and Sudbery, 2002; Noble and Johnson, 2007) . Autonomously replicating plasmids exist for C. albicans (Cannon et al., 1992) but their use is limited, since they are less stable than their S. cerevisiae counterparts. The construction of expression plasmids for C. albicans is most often achieved by cloning the gene of interest into these plasmids using Escherichia coli before integrating them into the C. albicans genome by homologous recombination (Sonneborn et al., 2000; Tripathi et al., 2002) .
In C. albicans, the position of marker genes (such as URA3 ) may substantially affect the expression level of the marker gene (Lay et al., 1998) and, more importantly, virulence in animal models of candidiasis (Sundström et al., 2002) . Further research has shown that integration of the URA3 in the RPS1 locus leads to expression levels that can restore virulence levels comparable to that of URA3 at its wild-type locus (Brand et al., 2004) . A series of vectors has been developed for integrating sequences at the RPS1 locus (Dennison et al., 2005; Murad et al., 2000) to prevent URA3 expression levels from influencing the virulence of these transformants. Since the effect of marker expression level on virulence is likely 934 N. Vieira et al. to be complex, the same vector integrated at the same genetic locus should be used for comparisons across genetic modifications if virulence is to be measured. The use of this system to overcome these positional effects of marker genes creates an implicit need to assemble genetic constructions in E. coli. However, this creates a problem if the C. albicans genetic modification cannot be propagated in this organism. Genes encoding eukaryotic membrane proteins are sometimes toxic to the extent that cloning is not possible in E. coli. Examples of these include S. cerevisiae hexose transporters HXT15 and HXT16 (Wieczorke et al., 1999) and the C. albicans JEN2 (Vieira et al., 2009) .
In S. cerevisiae, this can be overcome by direct cloning in yeast by in vivo gap repair. Orr-Weaver and Szostak (1983) were the first to report in vivo gap repair of two linear fragments into an episomal plasmid. This method has been widely used for direct high-throughput cloning of genes and libraries in yeast, where omitting E. coli in the cloning step simplifies the procedure and may increase the coverage of libraries. Therefore, we have created a set of three integrative C. albicans vectors, CIp10-2 µ, CIp20-2 µ and CIp30-2 µ, which permit in vivo assembly in S. cerevisiae. These vectors are based on the popular C. albicans integrative vectors CIp10 (Murad et al., 2000) , CIp20 and CIp30 (Dennison et al., 2005) . These vectors have one, two or three nutritional markers, respectively, for complementation of auxotrophic mutations (URA3, HIS1, ARG4 ), and they contain the C. albicans RPS1 gene, which is used to direct integration of the plasmid to this genomic locus.
The CIp20-2 µ vector was used to clone the C. albicans JEN2 gene in S. cerevisiae using gap repair, resulting in CIp20-2 µ -JEN2. Despite many attempts and the use of a range of alternative cloning strategies, we were unable to clone JEN2 in E. coli. We tried unsuccessfully an E. coli strain that maintains a low copy number of the vector (CopyCutter  EPI400  , EPICENTRE Biotechnologies, Madison, WI, USA), as well as constructing the vector by fusion PCR to avoid the E. coli cloning step. However, we were able to make CIp20-2 µ -JEN2 in S. cerevisiae and the JEN2 gene did not show any adverse effects in the yeast transformants. The cloned JEN2 was then reintegrated in the RPS1 genomic locus of a C. albicans jen2 knockout mutant (Vieira et al., 2009 ). The JEN2 reintegration, which was confirmed by diagnostic PCR, suppressed the phenotypes of the C. albicans jen2 knockout mutant. Growth on a medium containing succinic acid as sole carbon and energy source, as well as the ability to transport radiolabelled succinic acid by a mediated mechanism, was restored.
Materials and methods

Yeast strains, plasmids and growth conditions
Yeast strains and the plasmids used in this work are listed in Tables 1 and 2 , respectively. Strains were maintained on solid YPD medium (Sherman, 1991) . Growth of C. albicans strains was performed at 30
• C in synthetic complete (SC) medium
Plasmids for in vivo construction of integrative C. albicans vectors in S. cerevisiae Gietz and Sugino, 1988 without uracil or histidine (2% w/v glucose, 0.67% w/v yeast nitrogen base without amino acids and 2 g/l complete amino acid mixture without histidine or uracil; Kaiser, 1994) . The same medium was also prepared with succinic acid (1% v/v, pH 5.0) as carbon source. Growth of S. cerevisiae was performed in synthetic defined (SD) medium with the same composition but leaving out the amino acid mixture. Solid media were prepared by adding agar (2% w/v).
935
Transport assays
Yeast cells were grown in SC medium to obtain glucose repressed cells. For conditions of glucose derepression, cells grown in SC medium were washed twice in ice-cold deionized water and inoculated into fresh SC medium with succinic acid instead of glucose. Cells were harvested during the exponential phase (OD 640 nm = 0.5) by centrifugation, washed twice and resuspended in ice-cold deionized water to a final concentration of 25-35 mg dry weight/ml. Uptake rates of labelled succinic acid [(2,3-14 C) succinic acid (NEN Life Science); 5000 dpm/nM, pH 5.0] were estimated as described by Vieira et al. (2009) . A computer-assisted non-linear regression analysis program (GraphPad Software, San Diego, CA, USA) was used in order to determine the bestfitting transport kinetics to the experimental data and to estimate the kinetic parameters. All the experiments were performed in biological triplicates and the data presented represent average values, with error bars corresponding to the standard deviation (SD).
Construction of the CIpX0-2 µ vectors
CIp10, CIp20 and CIp30 were digested with StuI (AGG CCT), a restriction enzyme producing blunt ends that is normally used to linearize the vector before integration. The linearized vectors were ligated in vitro to a blunt PCR product of the S. cerevisiae 2 µ replication origin, containing one half StuI site at each end. The PCR product was amplified from the vector YEplac112 (Gietz and Sugino, 1988) with the primers 2 µ-CENARS AarI f and 2 µ-CENARS AarI r (Table  3) . Although many vectors carry the 2 µ sequence, the one in YEplac112 lacks a XbaI site due to directed mutagenesis, making this site available for manipulation elsewhere in the resulting vector. The ligation mixture was transformed directly to S. cerevisiae CEN.PK113-5D (ura3-52), using the high efficiency LiAc/ssDNA protocol (Gietz and Schiestl, 2007) . Transformants were selected on solid SD medium on the rationale that the C. albicans URA3 gene is able to complement the S. cerevisiae ura3 mutation. Transformants were found to be almost exclusively the correct plasmids, which was as expected, since none of the DNA fragments alone should be able to both propagate in S. cerevisiae and complement the ura3 mutation. Figure 1 . Schematic representation of the in vivo construction of CIp20-2 µ -JEN2 in S. cerevisiae. Only CIp20-2 µ is shown in this schematic overview but the methodology is similar for the CIp10-2 µ and CIp30-2 µ construction. CIp20 was initially digested with StuI and ligated to the 2 µ sequence from YEplac112 in vitro. The CIp20-2 µ vector was isolated from yeast and amplified in E. coli. CIp20-2 µ was then digested with MluI and SalI and co-transformed with a PCR-amplified JEN2 fragment into S. cerevisiae. Transformants were selected for uracil prototrophy. The circular vector was purified and used as template for PCR amplification. Finally, StuI digestion enabled the integration of the CIp20-2 µ plasmids at the RPS1 genomic locus. The image was made with the vector drawing software Simvector from Premier Biosoft International (http://www.premierbiosoft.com/plasmid maps/index.html)
The vectors were rescued from yeast by a combination of glass beads and E. coli plasmid mini preparation columns and transformed to E. coli. The vectors were purified from E. coli and analysed by digestion with StuI to confirm the release of the 2 µ sequence. The location and orientation of the 2 µ sequence was confirmed by PCR, using the primer pairs cip20 3551 fwd/2my 4507 rev and cip20 4936 fwd/2my 5676 rev, producing PCR products of 764 bp and 525 bp across the vector insert junctions, respectively. The vectors were given the names CIp10-2 µ, CIp20-2 µ and CIp30-2 µ (Figure 1 ). The sequences are available from GenBank under AccessionNos GU550 119, GU550 120 and GU550 121, respectively.
Construction of the CIp20-2 µ-JEN2 vector
The CIp20-2 µ vector was digested with MluI and Sal I in the presence of shrimp alkaline phosphatase to prevent religation of the vector. The enzymes were heat-inactivated according to the manufacturer's instructions. A 4295 bp fragment containing the C. albicans JEN2 locus was PCR-amplified from C. albicans genomic DNA, using the primers CaJEN2 rv lo and CaJEN2 fw sh (Table 3 ). The primers add 41 and 45 bp of homology to the CIp20-2 µ vector, up-and downstream of the MluI and Sal I sites. The linear vector and the PCR product were co-transformed into S. cerevisiae CEN.PK113-5D (ura3-52) and transformants were selected for uracil prototrophy on SD medium. The presence of the C. albicans JEN2 gene sequence in the transformants was confirmed by colony PCR, using the primers CaJEN2A1fwd and CaJEN2A2rev (Table 3) , which amplify a 764 bp PCR product internally in the JEN2 locus. The correct location of the JEN2 relative to the CIp20-2 µ vector was confirmed by PCR with the DRPS10fwd and DCaJEN2Rev primers (Table 3) , resulting in a 387 bp PCR product across the junction between the RPS1 gene of the vector and the JEN2 fragment.
Isolation of the CIp20-2 µ-CaJEN2 vector from S. cerevisiae Several protocols have been described for the isolation of plasmids from S. cerevisiae. Most protocols rely on transformation of E. coli of a crude yeast DNA preparation. Since it was not possible to propagate the JEN2 gene, a method was needed for direct isolation of plasmid DNA from yeast. S. cerevisiae has a strong cell wall and expresses more nuclease activities than the normally used laboratory strains of E. coli, so direct plasmid purification poses a technical problem. Direct isolation of plasmid DNA and separation of circular and linear DNA has been described using CsCl density gradient centrifugation, alkaline lysis of spheroplasts and partitioning of linear DNA using acid phenol. In our hands it was difficult to prepare DNA of sufficient quantity and quality using these methods. We therefore chose to use a combination of plasmid DNA preparation from S. cerevisiae and amplification of the vector using long PCR. We prepared a small quantity of plasmid DNA from the S. cerevisiae strain, using the same protocol combining glass beads and plasmid mini-preparation columns described earlier. We used 4% v/v of the isolated DNA as template for PCR, using the Long PCR Enzyme Mix (FERMENTAS) according to the manufacturer's recommendations and the primers 2my 4936 fwd and 2my 4057 rev. Four 50 µl PCR reaction were pooled, purified using the SureClean DNA cleanup kit (BIOLINE) and resuspended in 50 µl TE buffer. The PCR product was then digested with StuI by adding 7.4 µl buffer 2.5 µl StuI to 17.1 µl concentrated PCR product and used to transform C. albicans (Walther and Wendland, 2003) . Three independent transformants were obtained and the correct localization of the CIp20-JEN2 vector was confirmed by PCR, using primers HIS1 fw and RPS10 5ORF fwd (Table 3) . The first primer is plasmid-specific, whereas the second is located in the genomic RPS1 locus, producing a PCR product of 672 bp from the correct integrated plasmid (Figure 2 ).
Results and discussion
We have constructed a series of C. albicans integrative vectors (CIp10-2 µ, CIp20-2 µ and CIp30-2 µ) that permit plasmid construction in vivo by gap repair in S. cerevisiae. The vectors were constructed by combining a series of widely used C. albicans vectors (CIp10, −20 and −30) and a PCR product of the yeast 2 µ sequence. This sequence was inserted within the part of the vector that normally directs the chromosomal integration to a specific locus by ends-in homologous recombination. The enzyme used to linearize the vector before transformation in C. albicans was retained on each side of the 2 µ sequence, so that it is lost by linearization of the vector. This means that no • C in the following solid media: SC Glu (2%, w/v) and SC succinic acid (1%, w/v, pH 5.0). Cells were serially diluted and 5 µl drops of each dilution were spotted onto the plates: Wt, C. albicans RM1000 (JEN2/JEN2); jen2 + CIp20, CNV3 (jen2/jen2, RPS1-CIp20); jen2 + CIp20-JEN2, CNF5 (jen2/jen2, RPS1-CIp20-JEN2). (B) Initial uptake rates of (2,3-14 C) succinic acid at pH 5.0, as a function of succinic acid concentration after growth in medium containing succinic acid. ž, C. albicans RM1000 (JEN2/JEN2);
, CNV3 (jen2/jen2); , CNF5 (jen2/jen2, RPS1-CIp20-JEN2). Error bars represent SD of experiments carried out in biological triplicates S. cerevisiae sequences are transferred to C. albicans and the resulting integrated construct is not affected by the strategy. These vectors facilitate the cloning and integration of genes that are toxic in E. coli in C. albicans. A schematic view of the strategy is shown in Figure 1 .
The gene JEN2 encodes a C. albicans dicarboxylate transporter, the deletion of which from C. albicans impairs the mediated transport of succinic and malic acid and leads to a growth defect on these substrates (Vieira et al., 2009) . We have previously tried unsuccessfully to clone this gene in E. coli by ligating a JEN2 PCR product into a linearized CIp20 vector (Vieira et al., 2009) . Exhaustive attempts to clone JEN2 in E. coli using alternative strategies were also unsuccessful in our hands (unpublished). In the current study we amplified the same JEN2 fragment with primers adding a short stretch of homology to each side of the cloning site in CIp20-2 µ. The CIp20-2 µ and the PCR product were assembled in vivo and given the name CIp20-2 µ -JEN2. CIp20-2 µ -JEN2 was amplified by long PCR from S. cerevisiae, digested and integrated in a C. albicans jen2/jen2 double mutant, as described in Materials and methods. The correct integration was confirmed by colony PCR (Figure 2) .
The growth phenotypes of C. albicans RM1000 (wild-type), CNV3 (jen2/jen2 ) and the reintegrant CNF5 (jen2/jen2, RPS1-CIp20 -JEN2) were evaluated on both SC glucose 2% and SC succinic acid 1% solid media. No growth defect was found in SC glucose medium ( Figure 3A , left panel), as expected. A growth defect was observed on succinic acid for jen2/jen2 cells, and the insertion of CIp20-2 µ -JEN2 fully restored the ability to grow on this carbon source ( Figure 3A , right panel). In addition, we measured initial uptake rates of labelled succinic acid, pH 5.0, in cells grown on succinic acid. Like wild-type JEN2/JEN2 cells, the jen2/jen2/JEN2 strain displayed the ability to transport succinate by a mediated mechanism, indicating that the reintegration of JEN2 had suppressed this phenotype of the jen2/jen2 mutant.
